Early in the infection at week 1, the frequency of CD38+HLA-DR+CD8+ T cells in the survival group reached a mean of 29.4%, then gradually declined to 4.53% as the hypertensive patients clinically recovered at week 4 (Table 1). This evidence concerns the gene CD8A and infection.